000 | 01863 a2200517 4500 | ||
---|---|---|---|
005 | 20250517053659.0 | ||
264 | 0 | _c20160706 | |
008 | 201607s 0 0 eng d | ||
022 | _a1676-5680 | ||
024 | 7 |
_a10.4238/2015.September.8.12 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWang, W | |
245 | 0 | 0 |
_aRelationship between vitamin D receptor (VDR) polymorphisms and the efficacy of recombinant human growth hormone (rhGH) treatment in children with idiopathic short stature. _h[electronic resource] |
260 |
_bGenetics and molecular research : GMR _cSep 2015 |
||
300 |
_a10507-14 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aBinding Sites |
650 | 0 | 4 |
_aBody Height _xdrug effects |
650 | 0 | 4 | _aCDX2 Transcription Factor |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aDwarfism, Pituitary _xdrug therapy |
650 | 0 | 4 | _aExons |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Expression Regulation |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 |
_aHomeodomain Proteins _xgenetics |
650 | 0 | 4 |
_aHuman Growth Hormone _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInsulin-Like Growth Factor Binding Protein 3 _xgenetics |
650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xgenetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
650 | 0 | 4 | _aPromoter Regions, Genetic |
650 | 0 | 4 | _aProtein Binding |
650 | 0 | 4 |
_aReceptors, Calcitriol _xgenetics |
650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aLuo, X P | |
700 | 1 | _aCai, L X | |
700 | 1 | _aCui, Z R | |
700 | 1 | _aLuo, X Y | |
700 | 1 | _aLuo, R K | |
773 | 0 |
_tGenetics and molecular research : GMR _gvol. 14 _gno. 3 _gp. 10507-14 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.4238/2015.September.8.12 _zAvailable from publisher's website |
999 |
_c25289756 _d25289756 |